Silver Book Fact

In 2002, the cost of medications to treat diabetes was $7.3 billion.

PhRMA. Diabetes and Pharmaceutical Spending: New treatments, new solutions. PhRMA Two-Pager Plus. Spring 2003;

Reference

Title
Diabetes and Pharmaceutical Spending: New treatments, new solutions
Publication
PhRMA Two-Pager Plus
Publisher
PhRMA
Publication Date
Spring 2003
Authors
PhRMA

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Between 2009 and 2034, annual diabetes-related spending is expected to increase from $113 billion to $336 billion (2007 dollars).  
  • Annual health care spending attributable to prediabetes or diabetes could rise from $206 billion in 2011 to $512 billion by 2021, with a cumulative cost of approximately $3.5 trillion.  
  • In addition to Americans that have diabetes, an additional 30% of adults have pre-diabetes, a condition marked by elevated blood sugar that is not yet in the diabetic range.  
  • Roughly 38 percent of the adult population (about 100 million people) might have prediabetes in 2021- up from 29.7 percent in 2011.  
  • In 2010, the Centers for Disease Control and Prevention estimated that the US prevalence of diabetes was 8.3 percent.